Richard Newitter
Stock Analyst at Truist Securities
(3.79)
# 634
Out of 5,182 analysts
462
Total ratings
47.89%
Success rate
9.03%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Holdings | Maintains: Buy | $200 → $170 | $118.88 | +43.00% | 21 | Apr 15, 2026 | |
| VCEL Vericel | Maintains: Buy | $48 → $42 | $33.67 | +24.74% | 7 | Apr 15, 2026 | |
| SYK Stryker | Maintains: Hold | $395 → $380 | $327.30 | +16.10% | 26 | Apr 15, 2026 | |
| MDT Medtronic | Maintains: Hold | $103 → $95 | $82.00 | +15.85% | 20 | Apr 15, 2026 | |
| LNTH Lantheus Holdings | Maintains: Buy | $89 → $98 | $81.57 | +20.14% | 24 | Apr 15, 2026 | |
| ISRG Intuitive Surgical | Maintains: Buy | $650 → $580 | $451.29 | +28.52% | 33 | Apr 15, 2026 | |
| PODD Insulet | Maintains: Buy | $360 → $315 | $192.33 | +63.78% | 6 | Apr 15, 2026 | |
| INSP Inspire Medical Systems | Maintains: Hold | $70 → $64 | $52.03 | +23.01% | 32 | Apr 15, 2026 | |
| CARL Carlsmed | Maintains: Buy | $20 → $18 | $10.76 | +67.29% | 3 | Apr 15, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $92 → $90 | $59.52 | +51.21% | 23 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $18 | $12.27 | +46.70% | 7 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $35 | $20.03 | +74.74% | 6 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $30 | $24.76 | +21.16% | 17 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $19 → $20 | $16.25 | +23.08% | 11 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 → $24 | $13.82 | +73.66% | 2 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $97 | $85.62 | +13.29% | 13 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $82 → $80 | $62.60 | +27.80% | 4 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $92 → $89 | $79.71 | +11.65% | 23 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $370 → $374 | $327.00 | +14.37% | 8 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $4 → $3 | $1.83 | +63.93% | 19 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $145 | $122.11 | +18.75% | 7 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $93 → $105 | $93.83 | +11.90% | 30 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $15 | $10.52 | +42.59% | 19 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $124.75 | +9.82% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $92.69 | +21.91% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $7.09 | +182.09% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $77.82 | +5.37% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $156.69 | +59.55% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $2.41 | +978.84% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $195.20 | +294.47% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $5.35 | +273.83% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $35.89 | -24.77% | 5 | Feb 23, 2021 |
iRhythm Holdings
Apr 15, 2026
Maintains: Buy
Price Target: $200 → $170
Current: $118.88
Upside: +43.00%
Vericel
Apr 15, 2026
Maintains: Buy
Price Target: $48 → $42
Current: $33.67
Upside: +24.74%
Stryker
Apr 15, 2026
Maintains: Hold
Price Target: $395 → $380
Current: $327.30
Upside: +16.10%
Medtronic
Apr 15, 2026
Maintains: Hold
Price Target: $103 → $95
Current: $82.00
Upside: +15.85%
Lantheus Holdings
Apr 15, 2026
Maintains: Buy
Price Target: $89 → $98
Current: $81.57
Upside: +20.14%
Intuitive Surgical
Apr 15, 2026
Maintains: Buy
Price Target: $650 → $580
Current: $451.29
Upside: +28.52%
Insulet
Apr 15, 2026
Maintains: Buy
Price Target: $360 → $315
Current: $192.33
Upside: +63.78%
Inspire Medical Systems
Apr 15, 2026
Maintains: Hold
Price Target: $70 → $64
Current: $52.03
Upside: +23.01%
Carlsmed
Apr 15, 2026
Maintains: Buy
Price Target: $20 → $18
Current: $10.76
Upside: +67.29%
Boston Scientific
Apr 15, 2026
Maintains: Buy
Price Target: $92 → $90
Current: $59.52
Upside: +51.21%
Apr 15, 2026
Maintains: Buy
Price Target: $25 → $18
Current: $12.27
Upside: +46.70%
Mar 19, 2026
Upgrades: Buy
Price Target: $27 → $35
Current: $20.03
Upside: +74.74%
Mar 2, 2026
Maintains: Buy
Price Target: $47 → $30
Current: $24.76
Upside: +21.16%
Mar 2, 2026
Maintains: Hold
Price Target: $19 → $20
Current: $16.25
Upside: +23.08%
Feb 24, 2026
Reiterates: Buy
Price Target: $23 → $24
Current: $13.82
Upside: +73.66%
Feb 20, 2026
Maintains: Buy
Price Target: $95 → $97
Current: $85.62
Upside: +13.29%
Feb 17, 2026
Reiterates: Buy
Price Target: $82 → $80
Current: $62.60
Upside: +27.80%
Feb 11, 2026
Maintains: Hold
Price Target: $92 → $89
Current: $79.71
Upside: +11.65%
Jan 16, 2026
Downgrades: Hold
Price Target: $370 → $374
Current: $327.00
Upside: +14.37%
Dec 18, 2025
Maintains: Hold
Price Target: $4 → $3
Current: $1.83
Upside: +63.93%
Dec 18, 2025
Maintains: Buy
Price Target: $120 → $145
Current: $122.11
Upside: +18.75%
Nov 18, 2025
Reiterates: Buy
Price Target: $93 → $105
Current: $93.83
Upside: +11.90%
Oct 15, 2025
Maintains: Hold
Price Target: $13 → $15
Current: $10.52
Upside: +42.59%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $124.75
Upside: +9.82%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $92.69
Upside: +21.91%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $7.09
Upside: +182.09%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $77.82
Upside: +5.37%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $156.69
Upside: +59.55%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $2.41
Upside: +978.84%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $195.20
Upside: +294.47%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $5.35
Upside: +273.83%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $35.89
Upside: -24.77%